Literature DB >> 12726728

Nitric oxide and HSV vaginal infection in BALB/c mice.

Fabián Benencia1, Gisela Gamba, Hernan Cavalieri, Maria Cecilia Courreges, Ruben Benedetti, Soledad Maria Villamil, Ernesto Jorge Massouh.   

Abstract

Here we study the role of nitric oxide in the vaginal infection of Balb/c mice with herpes simplex virus type 2. Inducible nitric oxide synthase (iNOS) mRNA was detected by RT-PCR in vaginal tissue and inguinal lymph nodes early postinfection. iNOS was also found to be activated in cells recovered from vaginal washings of infected animals. Animals treated with aminoguanidine (AG), an iNOS inhibitor, showed a dose-dependent increase in vaginal pathology after viral infection compared to controls. Viral titers in vaginal washings and vaginas were higher in AG-treated mice. Treated animals presented higher PMN counts in vaginal washings compared to controls. Histopathology studies revealed a profound inflammatory exudate in vaginal tissue of treated animals. Finally, RT-PCR analysis showed increased expression of the chemokines MIP-2 and RANTES in vaginal tissue and inguinal lymph nodes of these animals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12726728     DOI: 10.1016/s0042-6822(02)00057-0

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

Review 1.  Herpes simplex virus and the chemokines that mediate the inflammation.

Authors:  D J J Carr; L Tomanek
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

2.  Nitric Oxide Attenuates Human Cytomegalovirus Infection yet Disrupts Neural Cell Differentiation and Tissue Organization.

Authors:  Rebekah L Mokry; Benjamin S O'Brien; Jacob W Adelman; Suzette Rosas; Megan L Schumacher; Allison D Ebert; Scott S Terhune
Journal:  J Virol       Date:  2022-07-07       Impact factor: 6.549

Review 3.  Nitric oxide: perspectives and emerging studies of a well known cytotoxin.

Authors:  William A Paradise; Benjamin J Vesper; Ajay Goel; Joshua D Waltonen; Kenneth W Altman; G Kenneth Haines; James A Radosevich
Journal:  Int J Mol Sci       Date:  2010-07-16       Impact factor: 5.923

Review 4.  Nitric oxide and cancer: a review.

Authors:  Sheetal Korde Choudhari; Minal Chaudhary; Sachin Bagde; Amol R Gadbail; Vaishali Joshi
Journal:  World J Surg Oncol       Date:  2013-05-30       Impact factor: 2.754

5.  Nitric oxide induces early viral transcription coincident with increased DNA damage and mutation rates in human papillomavirus-infected cells.

Authors:  Lanlan Wei; Patti E Gravitt; Hebin Song; Anastacia M Maldonado; Michelle A Ozbun
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

Review 6.  Macrophages and cytokines in the early defence against herpes simplex virus.

Authors:  Svend Ellermann-Eriksen
Journal:  Virol J       Date:  2005-08-03       Impact factor: 4.099

7.  Nitro-fatty acids are formed in response to virus infection and are potent inhibitors of STING palmitoylation and signaling.

Authors:  Anne Louise Hansen; Gregory J Buchan; Michael Rühl; Kojiro Mukai; Sonia R Salvatore; Emari Ogawa; Sidsel D Andersen; Marie B Iversen; Anne L Thielke; Camilla Gunderstofte; Mona Motwani; Charlotte T Møller; Andreas S Jakobsen; Katherine A Fitzgerald; Jessica Roos; Rongtuan Lin; Thorsten J Maier; Raphaela Goldbach-Mansky; Cathrine A Miner; Wei Qian; Jonathan J Miner; Rachel E Rigby; Jan Rehwinkel; Martin R Jakobsen; Hiroyuki Arai; Tomohiko Taguchi; Francisco J Schopfer; David Olagnier; Christian K Holm
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-30       Impact factor: 11.205

8.  FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling.

Authors:  Ali A Ashkar; Karen L Mossman; Brian K Coombes; Carlton L Gyles; Randy Mackenzie
Journal:  PLoS Pathog       Date:  2008-12-05       Impact factor: 6.823

9.  Methylomics of nitroxidative stress on precancerous cells reveals DNA methylation alteration at the transition from in situ to invasive cervical cancer.

Authors:  Po-Hsuan Su; Yao-Wen Hsu; Rui-Lan Huang; Yu-Chun Weng; Hui-Chen Wang; Yu-Chih Chen; Yueh-Ju Tsai; Chiou-Chung Yuan; Hung-Cheng Lai
Journal:  Oncotarget       Date:  2017-06-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.